A Hydrochloride, Verapamil CEP of the European Pharmacopoeia monograph is often referred to as a Hydrochloride, Verapamil Certificate of Suitability (COS). The purpose of a Hydrochloride, Verapamil CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Hydrochloride, Verapamil EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Hydrochloride, Verapamil to their clients by showing that a Hydrochloride, Verapamil CEP has been issued for it. The manufacturer submits a Hydrochloride, Verapamil CEP (COS) as part of the market authorization procedure, and it takes on the role of a Hydrochloride, Verapamil CEP holder for the record. Additionally, the data presented in the Hydrochloride, Verapamil CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Hydrochloride, Verapamil DMF.
A Hydrochloride, Verapamil CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Hydrochloride, Verapamil CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Hydrochloride, Verapamil suppliers with CEP (COS) on PharmaCompass.